Alison Kodjak | KERA News

Alison Kodjak

Alison Fitzgerald Kodjak is a health policy correspondent on NPR's Science Desk.

Her work focuses on the business and politics of health care and how those forces flow through to the general public. Her stories about drug prices, limits on insurance and changes in Medicare and Medicaid appear on NPR's shows and in the Shots blog.

She joined NPR in September 2015 after a nearly two-decade career in print journalism, where she won several awards—including three George Polk Awards—as an economics, finance, and investigative reporter.

She spent two years at the Center for Public Integrity, leading projects in financial, telecom, and political reporting. Her first project at the Center, "After the Meltdown," was honored with the 2014 Polk Award for business reporting and the Society of Professional Journalists Sigma Delta Chi award.

Her work as both reporter and editor on the foreclosure crisis in Florida, on Warren Buffet's predatory mobile home businesses, and on the telecom industry were honored by several journalism organizations. She was part of the International Consortium of Investigative Journalists team that won the 2015 Polk Award for revealing offshore banking practices.

Prior to joining the Center, Alison spent more than a decade at Bloomberg News, where she wrote about the convergence of politics, government, and economics. She interviewed chairmen of the Federal Reserve and traveled the world with two U.S. Treasury secretaries.

And as part of Bloomberg's investigative team she wrote about the bankruptcy of General Motors Corp. and the 2010 Gulf Oil Spill. She was part of a team at Bloomberg that successfully sued the Federal Reserve to release records of the 2008 bank bailouts, an effort that was honored with the 2009 George Polk Award. Her work on the international food price crisis in 2008 won her the Overseas Press Club's Malcolm Forbes Award.

Fitzgerald Kodjak and co-author Stanley Reed are authors of In Too Deep: BP and the Drilling Race that Took It Down, published in 2011 by John Wiley & Sons.

She's a graduate of Georgetown University and Northwestern University's Medill School of Journalism.

She raises children and chickens in suburban Maryland.

Georgia Republican Tom Price, who is President-elect Trump's choice to run the Department of Health and Human Services, is suddenly drowning in questions over the investments he has made while serving in the House of Representatives.

On Wednesday, Rep. Tom Price, R-Ga., goes before the Senate Committee on Health, Education, Labor and Pensions in his first grilling since he was nominated to lead the Department of Health and Human Services. This isn't an official confirmation hearing. That comes Jan. 24, before the Senate Finance Committee. But with outspoken senators such as Elizabeth Warren, D-Mass., and Bernie Sanders, I-Vt., on the HELP committee, Price is certain to face tough questions.

Here are five things to look out for:

Obamacare

Copyright 2017 NPR. To see more, visit http://www.npr.org/.

MICHEL MARTIN, HOST:

The Affordable Care Act brought the rate of uninsured Americans to a record low 9 percent in 2015. It's the major achievement of the controversial health care law and one the Obama administration likes to tout whenever it can.

Health and Human Services Secretary Sylvia Burwell did just that in an interview with NPR on Tuesday.

An overwhelming majority of people disapprove of Republican lawmakers' plan to repeal the Affordable Care Act without having a ready replacement for the health care law, according to a poll released Friday.

And judging by the letter-writing and lobbying in the first week of the new congressional session, many health care and business groups agree.

Lawmakers returned to Washington and wasted no time getting to work on the repeal of Obamacare.

Sen. Mike Enzi, R-Wyo., introduced a resolution just hours after the new Congress convened Tuesday that will serve as the vehicle for repealing much of the president's signature health care law.

Congress is back in session on Tuesday, and leaders of both houses say their first order of business will be to repeal Obamacare.

If they do that, it will be a slap in the face to President Obama just three weeks before he leaves the White House. The Affordable Care is the outgoing president's signature achievement, marked by an elaborate signing ceremony in March 2010 at the White House, with lofty speeches from the vice president and Obama himself.

To get a glimpse of where Medicaid may be headed after Donald Trump moves into the White House, it may be wise to look to Indiana.

That's where Seema Verma, Trump's pick to run the Centers for Medicare and Medicaid Services, comes from. And that's where she put her stamp on the state's health care program for the poor.

The pharmaceutical company Mylan says a generic version of its EpiPen anti-allergy device will be in pharmacies starting next week.

The company is introducing the generic at a price of $300 for a two-pack, half the cost of its brand-name cousin.

The Obama administration is trying to protect Planned Parenthood's federal funding before the president turns over the reins of government to Republicans who have historically been hostile to the family planning group.

Pages